Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 7, 2007 - Issue 3
Submit an article Journal homepage
72
Views
4
CrossRef citations to date
0
Altmetric
Drug Profile

Once-daily olopatadine ophthalmic solution 0.2% in the treatment of allergic conjunctivitis and rhinoconjunctivitis

William E Berger Clinical Professor, Department of Pediatrics, Division of Allergy & Immunology, University of California, Irvine, CA, USA; Allergy & Asthma Associates, 27800 Medical Center Road, Suite 244, Mission Viejo, CA 92691, USA. [email protected]
Pages 221-226 | Published online: 09 Jan 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ka Wai Kam, Li Jia Chen, Noel Wat & Alvin L. Young. (2017) Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis. Ocular Immunology and Inflammation 25:5, pages 668-682.
Read now

Articles from other publishers (3)

Yushun Xue, Wenzhi Zhang, Yan Lei & Minyan Dang. (2020) Novel Polyvinyl Pyrrolidone–Loaded Olopatadine HCl–Laden Doughnut Contact Lens to Treat Allergic Conjunctivitis. Journal of Pharmaceutical Sciences 109:5, pages 1714-1724.
Crossref
Hakika Erdogan & Ozlem Cam. (2018) The Effect Of Topical Antihistamines Used Single Dose Daily in Allergic Conjunctivitis. The Open Ophthalmology Journal 12:1, pages 330-337.
Crossref
Stephen V. Scoper, Gregg J. Berdy, Steven J. Lichtenstein, Jay M. Rubin, Marc Bloomenstein, Robert E. Prouty, Cullen T. Vogelson, Michael R. Edwards, Curtis Waycaster, Terri Pasquine, Robert D. Gross & Stella M. Robertson. (2007) Perception and quality of life associated with the use of olopatadine 0.2% (Pataday™) in patients with active allergic conjunctivitis. Advances in Therapy 24:6, pages 1221-1232.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.